Gemzar and haemolytic uraemic syndrome 
Gemzar and haemolytic uraemic syndrome Patient Reports February 13, 2012
Gemzar Side Effects Report #6114959-8
Gemzar side effect was reported by a Physician from UNITED STATES on May 01, 2008. Female patient, 61 years of age, was diagnosed with uterine mass and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, renal failure. Gemzar dosage: unknown. Patient recovered.
Gemzar Side Effects Report #4811749-0
Gemzar side effect was reported by a Consumer or non-health professional from NETHERLANDS on Oct 11, 2005. Male patient, 57 years of age, weighting 213.8 lb, was diagnosed with transitional cell carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, blood creatinine increased, haemolytic uraemic syndrome, hepatic function abnormal, metastases to central nervous system, thrombotic thrombocytopenic purpura, transitional cell carcinoma. Gemzar dosage: 2000 MG/M2/2 OTHER. During the same period patient was treated with CARBOPLATIN, FUROSEMIDE, ACENOCOUMAROL, NEURONTIN. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #4713720-6
Gemzar side effect was reported by a Pharmacist from UNITED STATES on June 28, 2005. Male patient, 41 years of age, was diagnosed with squamous cell carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, hypertension, renal artery stenosis, vasodilatation, visual disturbance. Gemzar dosage: 2400 MG/1. Patient recovered.
Gemzar Side Effects Report #5215589-2
Gemzar side effect was reported by a Physician from NETHERLANDS on Jan 16, 2007. Male patient, 33 years of age, weighting 154.3 lb, was diagnosed with seminoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome. Gemzar dosage: 900 MG/M2, UNK. Patient died on 11/01/2006.
Gemzar Side Effects Report #5299472-2
Gemzar side effect was reported by a Physician from NETHERLANDS on Apr 11, 2007. Male patient, 33 years of age, weighting 154.3 lb, was diagnosed with seminoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome. Gemzar dosage: 900 MG/M2, UNK. Patient died on 11/01/2006.
Gemzar Side Effects Report #5503146-X
Gemzar side effect was reported by a Physician from JAPAN on Oct 25, 2007. Female patient, weighting 103.6 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, cerebral infarction, haemolytic uraemic syndrome. Gemzar dosage: 1200 MG, OTHER. Patient died on 07/24/2007.
Gemzar Side Effects Report #5531896-8
Gemzar side effect was reported by a Physician from JAPAN on Nov 21, 2007. Female patient, weighting 103.6 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, cerebral infarction, haemolytic uraemic syndrome, malignant neoplasm progression. Gemzar dosage: 1200 MG, OTHER. Patient was hospitalized and became disabled. Patient died on 07/24/2007.
Gemzar Side Effects Report #5948236-2
Gemzar side effect was reported by a Physician from JAPAN on Oct 28, 2008. Male patient, weighting 158.7 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, upper gastrointestinal haemorrhage. Gemzar dosage: 1000 MG/M2, OTHER. Patient was hospitalized and became disabled. Patient died on 10/08/2008.
Gemzar Side Effects Report #6060887-6
Gemzar side effect was reported by a Physician from JAPAN on Jan 21, 2009. Male patient, 71 years of age, weighting 148.2 lb, was diagnosed with pancreatic carcinoma stage iii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: appendicitis
, haemolytic uraemic syndrome. Gemzar dosage: 1600 MG, OTHER. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5520500-0
Gemzar side effect was reported by a Physician from UNITED STATES on Nov 07, 2007. Female patient, 67 years of age, was diagnosed with pancreatic carcinoma stage ii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, haemorrhage intracranial, pneumonia
, respiratory failure, sepsis , thrombotic thrombocytopenic purpura. Gemzar dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, FUROSEMIDE, LISINOPRIL, DARBEPOETIN ALFA. Patient was hospitalized. Patient died.Gemzar Side Effects Report #5296316-X
Gemzar side effect was reported by a Consumer or non-health professional from NORWAY on Apr 02, 2007. Male patient, 72 years of age, weighting 185.2 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, haemolytic uraemic syndrome, listless, oedema peripheral, renal failure chronic, thrombotic thrombocytopenic purpura. Gemzar dosage: 1900 MG, WEEKLY WITH 1WK PAUSE EVERY 8 WEEKS. During the same period patient was treated with TENORMIN, NEXIUM, SIMVASTATIN, ADALAT, CREON, FURIX, PREDNISOLONE, INSULATARD. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5591949-5
Gemzar side effect was reported by a Physician from FRANCE on Jan 04, 2008. Female patient was diagnosed with pancreatic carcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, haemolytic uraemic syndrome, left ventricular failure, thrombocytopenia. Gemzar dosage: 1800 MG, WEEKLY (1/W). During the same period patient was treated with EUPANTOL, LASIX, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5675393-8
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 12, 2007. Female patient, 75 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with ANTIHYPERTENSIVES. Patient died on 02/01/2007.
Gemzar Side Effects Report #4648424-1
Gemzar side effect was reported by a Physician from on Apr 07, 2005. Male patient, 72 years of age, weighting 114.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, disseminated intravascular coagulation, haemolytic uraemic syndrome. Gemzar dosage: 1400 MG OTHER. During the same period patient was treated with SULPERAZON, KYTRIL, DECADRON. Patient recovered.
Gemzar Side Effects Report #4655900-4
Gemzar side effect was reported by a Physician from on Apr 20, 2005. Male patient, 72 years of age, weighting 114.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: catheter site haemorrhage, disseminated intravascular coagulation, haemolytic anaemia, haemolytic uraemic syndrome, liver disorder. Gemzar dosage: 1400 MG OTHER. During the same period patient was treated with SULPERAZON, KYTRIL, DECADRON. Patient recovered.
Gemzar Side Effects Report #4662767-7
Gemzar side effect was reported by a Physician from on Apr 20, 2005. Male patient, 72 years of age, weighting 114.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: catheter site haemorrhage, condition aggravated, disseminated intravascular coagulation, haemoglobin decreased, haemolytic anaemia, haemolytic uraemic syndrome, haemorrhagic diathesis, international normalised ratio increased, liver disorder. Gemzar dosage: 1400 MG OTHER. During the same period patient was treated with KYTRIL, DECADRON, SULPERAZON. Patient recovered.
Gemzar Side Effects Report #4607544-8
Gemzar side effect was reported by a Physician from on Feb 24, 2005. Male patient, 71 years of age, weighting 114.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: back pain
, blood pressure increased, condition aggravated, creatinine renal clearance decreased, haemolytic uraemic syndrome, iron deficiency anaemia, malignant neoplasm progression, marrow hyperplasia, oedema peripheral. Gemzar dosage: 1000 MG OTHER. During the same period patient was treated with RABEPRAZOLE, MUCOSTA, HARNAL, AMARYL. Patient recovered.Gemzar Side Effects Report #4710757-8
Gemzar side effect was reported by a Physician from JAPAN on June 15, 2005. Male patient, 71 years of age, weighting 114.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: back pain
, blood pressure increased, calcium ionised decreased, dialysis , haemolytic uraemic syndrome, hypocalcaemia, iron deficiency anaemia, malignant neoplasm progression, marrow hyperplasia. Gemzar dosage: 1000 MG OTHER. During the same period patient was treated with RABEPRAZOLE, MUCOSTA, HARNAL, AMARYL. Patient recovered.Gemzar Side Effects Report #4806796-9
Gemzar side effect was reported by a Physician from JAPAN on Sept 28, 2005. Male patient, 71 years of age, weighting 114.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: back pain
, blood pressure increased, carbohydrate antigen 19-9 increased, disease progression, haematuria, haemolytic uraemic syndrome, hypocalcaemia, iron deficiency anaemia, marrow hyperplasia. Gemzar dosage: 1000 MG OTHER. During the same period patient was treated with RABEPRAZOLE, MUCOSTA, HARNAL, AMARYL. Patient recovered.Gemzar Side Effects Report #5030746-6
Gemzar side effect was reported by a Pharmacist from FRANCE on June 02, 2006. Male patient, 71 years of age, weighting 99.21 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic anaemia, haemolytic uraemic syndrome, hypertension, renal failure, splenic infarction, thrombocytopenia. Gemzar dosage: 1000 MG/M2, WEEKLY (1/W), INTRAVENOUS. During the same period patient was treated with PLITICAN, DELURSAN, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #4600201-3
Gemzar side effect was reported by a Physician from on Feb 15, 2005. Male patient, 70 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, pleural effusion. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5113553-5
Gemzar side effect was reported by a Physician from GERMANY on Sept 01, 2006. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood thyroid stimulating hormone decreased, catheter sepsis, dialysis
, haemolytic uraemic syndrome, hypertensive crisis, infection , pneumonia , pulmonary oedema, renal failure acute. Gemzar dosage: 1000 MG/M2, DAILY (1/D), ORAL. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #6097307-1
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 17, 2009. Female patient, 67 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, thrombotic microangiopathy. Gemzar dosage: unknown. Patient recovered.
Gemzar Side Effects Report #6097308-3
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 17, 2009. Male patient, 65 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, thrombotic microangiopathy. Gemzar dosage: unknown. Patient recovered.
Gemzar Side Effects Report #5925793-3
Gemzar side effect was reported by a Physician from GERMANY on Oct 10, 2008. Male patient, weighting 167.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, staphylococcal infection
, subclavian vein thrombosis. Gemzar dosage: 1000 MG/M2, WEEKLY (1/W), 14 ADMINISTRATIONS. Patient was hospitalized. Patient died on 09/27/2008.Gemzar Side Effects Report #5940211-7
Gemzar side effect was reported by a Physician from GERMANY on Oct 23, 2008. Male patient, weighting 167.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, renal failure acute, staphylococcal infection
, subclavian vein thrombosis. Gemzar dosage: 1000 MG/M2, WEEKLY (1/W), 14 ADMINISTRATIONS. Patient was hospitalized. Patient died on 09/27/2008.Gemzar Side Effects Report #4648942-6
Gemzar side effect was reported by a Physician from on Apr 11, 2005. Female patient, 57 years of age, was diagnosed with ovarian epithelial cancer stage iii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, granulocytopenia, haemolytic uraemic syndrome, macrocytosis, mucosal inflammation, non-cardiogenic pulmonary oedema, oedema peripheral, pericardial effusion. Gemzar dosage: 2000 MG/M2 OTHER. During the same period patient was treated with DOXORUBICIN. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #4648811-1
Gemzar side effect was reported by a Physician from on Apr 11, 2005. Female patient, 57 years of age, was diagnosed with ovarian epithelial cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine increased, blood lactate dehydrogenase increased, blood pressure increased, haemolytic uraemic syndrome, stomatitis. Gemzar dosage: 1500 MG/M2 OTHER. During the same period patient was treated with DOXORUBICIN. Patient was hospitalized. Patient died on 11/01/2003.
Gemzar Side Effects Report #4648960-8
Gemzar side effect was reported by a Physician from on Apr 11, 2005. Female patient, 57 years of age, was diagnosed with ovarian epithelial cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, acute respiratory failure, haemolytic anaemia, haemolytic uraemic syndrome, hypertension, hypervolaemia, lung injury, pleural effusion. Gemzar dosage: 2000 MG/M2 OTHER. During the same period patient was treated with DOXORUBICIN. Patient was hospitalized. Patient died.
Gemzar Side Effects Report #5609360-7
Gemzar side effect was reported by a Physician from SWITZERLAND on Nov 29, 2007. Female patient, 78 years of age, weighting 132.3 lb, was diagnosed with ovarian cancer metastatic, hypertension and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, renal failure chronic, sepsis
. Gemzar dosage: 1600 MG, DAY 1, 8 AND 15. During the same period patient was treated with COVERSUM, ADALAT CR. Patient was hospitalized and became disabled. Patient died on 01/26/2008.Gemzar Side Effects Report #6106427-4
Gemzar side effect was reported by a Physician from GERMANY on Feb 25, 2009. Female patient, 58 years of age, weighting 180.8 lb, was diagnosed with ovarian cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, haemolytic uraemic syndrome, leukopenia, pleural effusion, pulmonary congestion, renal failure acute. Gemzar dosage: 1000 MG/M2: 75% DOSE REDUCTION FOR C2/3.50% DOSE REDUCTION FOR C5/7. During the same period patient was treated with KEPPRA, ERGENYL CHRONO, BISOPROLOL, ZOLPIDEM. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5690278-9
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 19, 2008. Female patient, 53 years of age, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome. Gemzar dosage: unknown. Patient died.
Gemzar Side Effects Report #5675384-7
Gemzar side effect was reported by a Physician from UNITED STATES on Mar 28, 2007. Female patient, 51 years of age, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome. Gemzar dosage: 1900 MG, INTRAVENOUS;1900 MG, INTRAVENOUS; 1900 MG, INTRAVENOUS; 1900 MG, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #4992754-0
Gemzar side effect was reported by a Health Professional from UNITED STATES on Jan 20, 2005. Female patient, 51 years of age, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, haemolytic uraemic syndrome. Gemzar dosage: unknown. During the same period patient was treated with ALOXI. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #4878595-3
Gemzar side effect was reported by a Health Professional from UNITED STATES on Jan 10, 2006. Female patient, weighting 123.0 lb, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dialysis
, haemolytic uraemic syndrome, nephrogenic fibrosing dermopathy. Gemzar dosage: 1750MG WEEKLY X ' S ^3 WEEKS IV DRIP. Patient recovered.Gemzar Side Effects Report #5848528-1
Gemzar side effect was reported by a Physician from UNITED KINGDOM on Aug 05, 2008. Male patient, weighting 224.9 lb, was diagnosed with non-small cell lung cancer stage iv, vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, pulmonary embolism
, renal failure acute. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, NSAID, IBUPROFEN, DEXAMETHASONE, ONDANSETRON, ACETAMINOPHEN. Patient was hospitalized. Patient died on 03/11/2008.Gemzar Side Effects Report #5874255-0
Gemzar side effect was reported by a Physician from UNITED KINGDOM on Aug 26, 2008. Male patient, weighting 224.9 lb, was diagnosed with non-small cell lung cancer stage iv, vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, haemolytic uraemic syndrome, loss of consciousness, pulmonary embolism . Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, NSAID, IBUPROFEN, DEXAMETHASONE, ONDANSETRON, ACETAMINOPHEN. Patient was hospitalized. Patient died on 03/11/2008.Gemzar Side Effects Report #5966096-0
Gemzar side effect was reported by a Physician from UNITED STATES on Nov 13, 2008. Female patient, weighting 149.0 lb, was diagnosed with non-small cell lung cancer stage ii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: diabetic neuropathy, glomerulosclerosis, haemolytic uraemic syndrome, nephrosclerosis, platelet count decreased, renal failure acute, renal failure chronic, thrombotic microangiopathy, tubulointerstitial nephritis. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, ADALAT, AVAPRO, VITAMIN B, FISH OIL, GLUCOPHAGE, YEAST. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #6089369-2
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 17, 2009. Female patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: convulsion, haemolytic uraemic syndrome, haemorrhage intracranial, hemiparesis, hypertension. Gemzar dosage: unknown. Patient was hospitalized. Patient died.
Gemzar Side Effects Report #4611196-0
Gemzar side effect was reported by a Physician from on Feb 19, 2004. Female patient, 53 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthenia, haemolytic uraemic syndrome. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOTERE. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5071765-3
Gemzar side effect was reported by a Consumer or non-health professional from FRANCE on July 18, 2006. Male patient, 52 years of age, weighting 105.8 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: epistaxis, haemolytic uraemic syndrome, international normalised ratio increased, peripheral ischaemia. Gemzar dosage: 1250 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with CISPLATIN, THERAPEUTIC RADIOPHARMACEUTICALS, PREVISCAN. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #4970861-6
Gemzar side effect was reported by a Health Professional from FRANCE on Mar 27, 2006. Male patient, 52 years of age, weighting 105.8 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, epistaxis, haemolytic uraemic syndrome, international normalised ratio increased, peripheral ischaemia, thrombocytopenia. Gemzar dosage: 1250 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with CISPLATIN, THERAPEUTIC RADIOPHARMACEUTICALS, PREVISCAN. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5006737-8
Gemzar side effect was reported by a Consumer or non-health professional from FRANCE on May 04, 2006. Male patient, 52 years of age, weighting 105.8 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: epistaxis, haemolytic uraemic syndrome, international normalised ratio increased, peripheral ischaemia. Gemzar dosage: 1250 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS, PREVISCAN. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5957227-7
Gemzar side effect was reported by a Physician from UNITED STATES on Nov 05, 2008. Female patient, weighting 149.0 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: glomerulosclerosis, haemolytic uraemic syndrome, nephrosclerosis, peritoneal dialysis, renal failure acute, renal failure chronic, thrombotic microangiopathy, tubulointerstitial nephritis. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, ADALAT, AVAPRO, VITAMIN B, FISH OIL, GLUCOPHAGE, YEAST. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #4578044-9
Gemzar side effect was reported by a Physician from on Jan 28, 2005. Male patient, 47 years of age, was diagnosed with non-hodgkin's lymphoma recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bone marrow depression, haemodialysis, haemolytic uraemic syndrome, lymphoma
, malignant neoplasm progression, multi-organ failure. Gemzar dosage: 1000 MG/M2/PER INFUSION OTHER. During the same period patient was treated with VINORELBINE, METHOTREXATE, DEXAMETHASONE. Patient was hospitalized. Patient died on 11/02/2003.Gemzar Side Effects Report #4611167-4
Gemzar side effect was reported by a Health Professional from on Aug 16, 2004. Female patient, 60 years of age, weighting 216.1 lb, was diagnosed with neoplasm recurrence, ovarian germ cell cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome. Gemzar dosage: 1000 MG/M2 WEEK. During the same period patient was treated with COREG, NORVASC, LASIX, PREDNISONE, LOVASTATIN, FOLIC ACID. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #4545500-9
Gemzar side effect was reported by a Health Professional from on Dec 13, 2004. Female patient, 70 years of age, was diagnosed with neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, pancytopenia. Gemzar dosage: unknown. During the same period patient was treated with PROCRIT. Patient recovered.
Gemzar Side Effects Report #6094286-8
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 17, 2009. Female patient, 61 years of age, was diagnosed with neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure congestive, haemolytic uraemic syndrome, renal failure chronic, thrombotic microangiopathy. Gemzar dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient recovered.
Gemzar Side Effects Report #4577898-X
Gemzar side effect was reported by a Physician from on Jan 24, 2005. Female patient, 36 years of age, was diagnosed with neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, leukopenia. Gemzar dosage: 1600 MG. During the same period patient was treated with TAXOL. Patient recovered.
Gemzar Side Effects Report #4579480-7
Gemzar side effect was reported by a Physician from on Jan 28, 2005. Male patient, 38 years of age, was diagnosed with hodgkin's disease
and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, blood creatinine increased, blood lactate dehydrogenase increased, dialysis , epilepsy , haemolytic uraemic syndrome, hodgkin's disease , hypertension, malignant neoplasm progression. Gemzar dosage: 1000 MG/M2 PER INFUSION OTHER. During the same period patient was treated with RITUXIMAB, CISPLATIN. Patient was hospitalized and became disabled. Patient died on 11/01/2003.Gemzar Side Effects Report #4992315-3
Gemzar side effect was reported by a Health Professional from UNITED STATES on May 19, 2005. Female patient, 39 years of age, was diagnosed with cervix carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5581814-1
Gemzar side effect was reported by a Physician from UNITED STATES on Dec 24, 2007. Female patient, 59 years of age, was diagnosed with breast cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, hypertension, renal failure, thrombotic thrombocytopenic purpura. Gemzar dosage: 1250 MG/M2, UNK. During the same period patient was treated with TAXOL. Patient recovered.
Gemzar Side Effects Report #5626318-2
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 04, 2008. Female patient, 59 years of age, was diagnosed with breast cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, malignant neoplasm progression, renal failure, thrombotic thrombocytopenic purpura. Gemzar dosage: 1250 MG/M2, UNK. During the same period patient was treated with TAXOL. Patient died.
Gemzar Side Effects Report #5581816-5
Gemzar side effect was reported by a Physician from UNITED STATES on Dec 24, 2007. Female patient, 48 years of age, was diagnosed with breast cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, haemolytic uraemic syndrome, renal failure, thrombotic thrombocytopenic purpura. Gemzar dosage: 1250 MG/M2, DAY 1 + 8. Patient recovered.
Gemzar Side Effects Report #5626319-4
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 04, 2008. Female patient, 48 years of age, was diagnosed with breast cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, haemolytic uraemic syndrome, renal failure, thrombotic thrombocytopenic purpura. Gemzar dosage: 1250 MG/M2, DAY 1 + 8. Patient recovered.
Gemzar Side Effects Report #4681601-2
Gemzar side effect was reported by a Physician from on May 17, 2005. Female patient, 47 years of age, weighting 158.7 lb, was diagnosed with breast cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, disease progression, haemolytic uraemic syndrome, hypertension, nausea
, neurological examination abnormal, oedema, rash . Gemzar dosage: 1141 MG/M2. During the same period patient was treated with ZOMETA, DIPHENHYDRAMINE, ALOXI, DECADRON, INSULIN, LISINOPRIL, LOVASTATIN, SYNTHROID. Patient died on 04/15/2005.Gemzar Side Effects Report #5013882-X
Gemzar side effect was reported by a Health Professional from FRANCE on May 10, 2006. Female patient, 65 years of age, weighting 143.3 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: arthritis
, blood lactate dehydrogenase increased, disease progression, eyelid oedema, haemolytic uraemic syndrome, lung infection, metabolic acidosis, oedema peripheral. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #4776341-5
Gemzar side effect was reported by a Physician from UNITED KINGDOM on Sept 05, 2005. Female patient, 64 years of age, weighting 154.3 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood creatinine increased, colitis, dyspnoea, haemolytic uraemic syndrome, oedema peripheral, platelet count decreased, renal impairment. Gemzar dosage: 1700 MG. During the same period patient was treated with PACLITAXEL, DOMPERIDONE, LANSOPRAZOLE. Patient was hospitalized. Patient died on 08/22/2005.
Gemzar Side Effects Report #4777831-1
Gemzar side effect was reported by a Physician from UNITED KINGDOM on Sept 05, 2005. Female patient, 64 years of age, weighting 154.3 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: colitis, dyspnoea, haemolytic uraemic syndrome, oedema peripheral, platelet count decreased, renal impairment. Gemzar dosage: 1700 MG. During the same period patient was treated with PACLITAXEL, DOMPERIDONE, LANSOPRAZOLE. Patient was hospitalized. Patient died on 08/22/2005.
Gemzar Side Effects Report #4825048-4
Gemzar side effect was reported by a Physician from UNITED KINGDOM on Oct 26, 2005. Female patient, 64 years of age, weighting 154.3 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: colitis, dyspnoea, haemolytic uraemic syndrome, metastases to spine, oedema peripheral, platelet count decreased, renal impairment. Gemzar dosage: 1700 MG. During the same period patient was treated with PACLITAXEL, DOMPERIDONE, LANSOPRAZOLE. Patient was hospitalized. Patient died on 08/22/2005.
Gemzar Side Effects Report #5341788-5
Gemzar side effect was reported by a Physician from FRANCE on May 28, 2007. Female patient, 63 years of age, was diagnosed with breast cancer metastatic, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: angiodermatitis, escherichia sepsis, haemolytic uraemic syndrome, livedo reticularis. Gemzar dosage: 2000 MG, OTHER. During the same period patient was treated with SERESTA, OSMOTAN, ZOFRAN, DAFLON. Patient recovered.
Gemzar Side Effects Report #4611103-0
Gemzar side effect was reported by a Physician from on Sept 15, 2004. Female patient, 52 years of age, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, thrombotic thrombocytopenic purpura. Gemzar dosage: 1770 MG EVERY OTHER WEEK. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #4992588-7
Gemzar side effect was reported by a Health Professional from UNITED STATES on Sept 23, 2005. Female patient, 50 years of age, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #4674466-6
Gemzar side effect was reported by a Physician from on May 04, 2005. Female patient, 47 years of age, weighting 158.7 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, blood creatinine increased, blood lactate dehydrogenase increased, disease progression, haemolysis, haemolytic uraemic syndrome, hypertension, nausea
, oedema. Gemzar dosage: 1141 MG/M2. During the same period patient was treated with ZOMETA, DIPHENHYDRAMINE, ALOXI, DECADRON, INSULIN, LISINOPRIL, LOVASTATIN, SYNTHROID. Patient died.Gemzar Side Effects Report #6112623-2
Gemzar side effect was reported by a Physician from UNITED STATES on Mar 06, 2009. Female patient, 45 years of age, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood creatinine increased, haemolytic uraemic syndrome, malignant neoplasm progression, microangiopathy. Gemzar dosage: unknown. During the same period patient was treated with HERCEPTIN. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5315658-2
Gemzar side effect was reported by a Pharmacist from UNITED STATES on Apr 30, 2007. Female patient, 44 years of age, weighting 170.4 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: chest discomfort, dyspnoea, haemolytic uraemic syndrome, pleural effusion, tachycardia. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #6094282-0
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 17, 2009. Female patient, 65 years of age, was diagnosed with breast cancer
and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure congestive, haemolytic uraemic syndrome, renal failure chronic, thrombotic microangiopathy. Gemzar dosage: unknown. Patient recovered.Gemzar Side Effects Report #4752462-8
Gemzar side effect was reported by a Physician from UNITED KINGDOM on Aug 08, 2005. Female patient, 65 years of age, was diagnosed with breast cancer
and was treated with Gemzar. After drug was administered, patient experienced the following side effects: capillary leak syndrome, colitis, haemolytic uraemic syndrome, nephrotic syndrome. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #6094284-4
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 17, 2009. Female patient, 55 years of age, was diagnosed with breast cancer
and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure congestive, haemolytic uraemic syndrome, headache , hypertension, hypertensive encephalopathy, pericardial effusion. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5309911-6
Gemzar side effect was reported by a Physician from UNITED STATES on Apr 24, 2007. Female patient, 45 years of age, was diagnosed with breast cancer
and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, pleural effusion, pulmonary oedema. Gemzar dosage: 800 MG/M2, OTHER. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5407411-6
Gemzar side effect was reported by a Physician from UNITED STATES on Aug 01, 2007. Female patient, 45 years of age, was diagnosed with breast cancer
and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, pleural effusion, pulmonary oedema, renal failure chronic. Gemzar dosage: 800 MG/M2, OTHER. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5505421-1
Gemzar side effect was reported by a Physician from UNITED STATES on Oct 26, 2007. Female patient was diagnosed with breast cancer
and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, thrombotic thrombocytopenic purpura. Gemzar dosage: unknown. During the same period patient was treated with TAXOL. Patient recovered.Gemzar Side Effects Report #4970840-9
Gemzar side effect was reported by a Physician from UNITED STATES on Mar 20, 2006. Female patient, 50 years of age, was diagnosed with biliary cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, thrombotic thrombocytopenic purpura. Gemzar dosage: unknown. Patient recovered.
Gemzar Side Effects Report #5950102-3
Gemzar side effect was reported by a Physician from JAPAN on Nov 05, 2008. Male patient was diagnosed with bile duct cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, hepatic failure, malignant neoplasm progression, thrombotic thrombocytopenic purpura. Gemzar dosage: 400 MG, WEEKLY (1/W). Patient died on 10/07/2008.
Gemzar Side Effects Report #5977285-3
Gemzar side effect was reported by a Health Professional from JAPAN on Nov 25, 2008. Male patient, weighting 112.4 lb, was diagnosed with bile duct cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, hepatic failure, malignant neoplasm progression, thrombotic thrombocytopenic purpura. Gemzar dosage: 400 MG, WEEKLY (1/W). During the same period patient was treated with LOXONIN, MUCOSTA, VOLTAREN, LEPETAN. Patient died on 10/07/2008.
Gemzar Side Effects Report #4579481-9
Gemzar side effect was reported by a Physician from on Jan 28, 2005. Female patient, 61 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bile duct cancer, haemolytic uraemic syndrome, malignant neoplasm progression, platelet count decreased, red blood cell schistocytes present, renal impairment, reticulocyte count increased. Gemzar dosage: 1000 MG/M2/PER INFUSION OTHER. Patient was hospitalized. Patient died.
Gemzar Side Effects Report #5675380-X
Gemzar side effect was reported by a Physician from UNITED STATES on July 02, 2007. Female patient, 50 years of age, weighting 209.9 lb, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood amylase increased, haemolytic uraemic syndrome, lipase increased, transaminases increased. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with INSULIN, ENALAPRIL MALEATE, METOPROLOL TARTRATE. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5874251-3
Gemzar side effect was reported by a Physician from JAPAN on Aug 26, 2008. Male patient, 43 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, hepatic function abnormal, pericardial effusion, renal impairment. Gemzar dosage: 400 MG, OTHER. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5940208-7
Gemzar side effect was reported by a Physician from JAPAN on Oct 23, 2008. Male patient, 43 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, hepatic function abnormal, malignant neoplasm progression, pericardial effusion, renal impairment. Gemzar dosage: 400 MG, OTHER. Patient was hospitalized. Patient died on 10/01/2008.
Gemzar Side Effects Report #6055672-5
Gemzar side effect was reported by a Physician from GERMANY on Jan 19, 2009. Male patient, weighting 154.3 lb, was diagnosed with bile duct cancer, headache
, vomiting, nausea , pain and was treated with Gemzar. After drug was administered, patient experienced the following side effects: foot fracture, haemolytic uraemic syndrome. Gemzar dosage: 1650 MG, NEARLY 3TIMES A MONTH. During the same period patient was treated with ASPIRIN, ERYPO, KEVATRIL, METOCLOPRAMIDE, NEUPOGEN, ACETAMINOPHEN, URSO FALK. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #5907362-4
Gemzar side effect was reported by a Physician from GERMANY on Sept 22, 2008. Male patient, 42 years of age, was diagnosed with adrenocortical carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: adrenal neoplasm, blood creatinine increased, blood pressure increased, blood urea increased, c-reactive protein increased, confusional state, haemolytic uraemic syndrome, headache
. Gemzar dosage: 1000 MG/M2, (CUMULATED DOSE APPROX. 20 G).. Patient was hospitalized. Patient recovered.Gemzar Side Effects Report #4625656-X
Gemzar side effect was reported by a Physician from on Mar 15, 2005. Female patient, 74 years of age, was diagnosed with adenocarcinoma pancreas and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthenia, dyspnoea exertional, haemolytic uraemic syndrome, headache
, hypertension, malignant neoplasm progression, oedema peripheral, weight increased. Gemzar dosage: unknown. Patient was hospitalized. Patient died on 01/01/2001.Gemzar Side Effects Report #4988524-X
Gemzar side effect was reported by a Physician from FRANCE on Apr 10, 2006. Female patient, 74 years of age, was diagnosed with adenocarcinoma pancreas and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthenia, biopsy kidney abnormal, dyspnoea exertional, haemolytic uraemic syndrome, headache
, hypertension, malignant neoplasm progression, myocardial ischaemia, oedema peripheral. Gemzar dosage: unknown. Patient was hospitalized. Patient died on 01/01/2001.Gemzar Side Effects Report #4625657-1
Gemzar side effect was reported by a Physician from on Mar 15, 2005. Female patient, 66 years of age, was diagnosed with adenocarcinoma pancreas and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, blood pressure increased, haemolytic uraemic syndrome, hypotension, malignant neoplasm progression, oedema peripheral, renal failure, thrombocytopenia. Gemzar dosage: unknown. Patient was hospitalized and became disabled. Patient died on 02/01/2003.
Gemzar Side Effects Report #5002356-8
Gemzar side effect was reported by a Physician from FRANCE on May 04, 2006. Male patient, 65 years of age, weighting 143.3 lb, was diagnosed with adenocarcinoma pancreas and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood pressure increased, carbohydrate antigen 19-9 increased, fall
, haemolytic uraemic syndrome, pneumonia aspiration. Gemzar dosage: unknown. During the same period patient was treated with FLUOROURACIL, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient died on 02/21/2005.Gemzar Side Effects Report #4625592-9
Gemzar side effect was reported by a Physician from on Mar 15, 2005. Male patient, 61 years of age, was diagnosed with adenocarcinoma pancreas and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, asthenia, blood sodium increased, dyspnoea, fluid retention, gastrointestinal disorder, haemodialysis, haemolytic uraemic syndrome, hypertension. Gemzar dosage: unknown. Patient was hospitalized and became disabled. Patient died on 04/01/2003.
Gemzar Side Effects Report #5886227-0
Gemzar side effect was reported by a Physician from FRANCE on Sept 03, 2008. Male patient, 51 years of age, was diagnosed with adenocarcinoma pancreas and was treated with Gemzar. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia, haemolytic uraemic syndrome. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5337621-8
Gemzar side effect was reported by a Physician from UNITED STATES on Dec 11, 2006. Male patient, 77 years of age, was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome. Gemzar dosage: 1000 MG/M2. Patient recovered.
Gemzar Side Effects Report #4992384-0
Gemzar side effect was reported by a Physician from UNITED STATES on Apr 07, 2005. Male patient, 48 years of age, was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5478561-3
Gemzar side effect was reported by a Physician from JAPAN on Sept 25, 2007. Female patient, weighting 100.5 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, pericardial effusion. Gemzar dosage: 1400 MG, UNK. During the same period patient was treated with ELPLAT, KYTRIL. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5499355-9
Gemzar side effect was reported by a Physician from JAPAN on Oct 16, 2007. Female patient, weighting 100.5 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic uraemic syndrome, pericardial effusion. Gemzar dosage: 1400 MG, UNK. During the same period patient was treated with ELPLAT, KYTRIL. Patient was hospitalized. Patient recovered.